Антагонисты и ингибиторы лейкотриенов в терапии бронхиальной астмы
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Полный текст:
Об авторах
В. Л. Ковалева
ВНЦ БАВ;
НИИ пульмонологии М3 РФ
Россия
Россия
А. Г. Чучалин
ВНЦ БАВ;
НИИ пульмонологии М3 РФ
Россия
Россия
Н. А. Колганова
ВНЦ БАВ;
НИИ пульмонологии М3 РФ
Россия
Россия
Список литературы
1. Abraham W.M., Stevenson J.S. A new leukotriene D4 antagonist L-660711 blocks allergen-induced late responses in allergic sheep / / FASEB J .- 1988.- Vol.2.- P.4425.
2. Adelroth E., Morris M.M., Hargreave F.E., O’Byrne P.M. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patient with asthma and normal controls / / N. Engl. J. Med.- 1986.- Vol.315.- P.480-484.
3. Ann J.P., Lee T.H. Sulphidopeptide leukotriene in asthma / / # Clin. Sci.- 1993.- Vol.84.- P.501-510.
4. Barnes N.C., Kuitert L. Influence of leukotriene antagonists on baseline pulmonary function and asthm atic responses / / Adv. Prostagland. Thrombox. Leukotr. Res.- 1994.- Vol.22.- P.217-226.
5. Barnes P.J., Lee Т.Н. Recent advances in asthma / / Postgrad. Med. J.- 1992.- Vol.68.- P.942-953.
6. Bateman E.D., Holgate S.Т., Binks S.М., Tams I.P. A multicentre study to assess the steroid - sparing potential of Accolate (zafirlucast; 20m g b d ) / / Allergy.- 1995.- Vol.50, Suppl.26.- P.320.
7. Becker A.B., Black C., Lilley M.K. et al. Antiasthmatic effects of leukotriene biosynthesis inhibitor (MK-0591) in allergic dogs / / J. Appl. Physiol.- 1995.- Vol.78.- P.615-622.
8. Bel E.H., Tanaka W., Spector R. et al. MK-886, an effective oral leukotriene biosynthesis inhibitor on antigen-induced early and late asthm atic reactions in man / / Am. Rev. Respir. Dis.- 1990.- Vol.141.- P.A31.
9. Bel E.H ., van der Veen H., Kramps I.A. et al. Maximal airway narrow ingto inhaled leukotriene D4 in normal subjects / / Ibid.- 1987.- Vol.136.- P.979-984.
10. Bisgaard H., Groth S., Madsen F. Bronchial hyperreactivity to leukotriene D4 and histamine to exogenous asthma / / Br. Med. j . _ 1985.- Vol.290.- P.1468-1471.
11. Bochnowicz J., Underwood D.C. Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea-pig / / Prostagland. Leukotr. Essent Fatty Acids.- 1995.- Vol.52.- P.403-411.
12. Bone R.C. Asthma: new treatments will improve disease management / / Clin. Pulmon. M ed.- 1995.- Vol.2, № 5.- P.249-257.
13. Boot J.R., Bond A., Thomas K.H. et al. The pharmacology of LY 290324 in the guinea-pig: an orally active, potent and selective cysteinyl leikotriene receptor antogonist / / Eur. J. Pharmacol.- 1993.- Vol.231.- P.83-89.
14. Borgeat P., Samuelsson B. Leukotrienes: M ediators of immediate hypersensitivity reactions and infflammation / / Proc. Natl. Acad. Sci. USA.- 1979.- Vol.76.- P.3213-3217.
15. Brooks D.W., Summers J.B., Stewart A.O. et al. Novel inhibitors of leukotriene biosynthesis / / Perspectives in Medicinal Chemistry.- Weinheim, 1993.- P .119-134.
16. Busse W.W., Gaddy J.N. The role of leukotriene antagonists and inhibitors in the treatm ent airway disease / / Am. Rev. Respir. Dis.- 1991,- V ol.143.- P.103-107.
17. Brideau C., Chan C., Charleson S. et al. Pharmacology of MK-0591, a potent orally active leukotriene biosynthesis inhibitor / / Can. J. Physiol. Pharmacol.- 1992.- Vol.70.- P.799-807.
18. Busse W.W., Gaddy J.N. The role of leukotriene antagonists and inhibitors in the treatm ent of airway disease / / Am. Rev. Respir. Dis.- 1991,- V ol.143, Pt 2.- P.S103-S107.
19. Calhoun W.J., Lavins B.J., Glass M. Effect of ‘Accolate’ (zafirlucast) on bronchoalveolar lavage fluid (BAL) after segmental antigen bronchoprovocation (SBP) in patients with mild to moderate asthm a / / Am. J. Respir. Crit. Care M ed.- 1995.- Vol.151, Pt 2.- P.A42.
20. Calverley P.M.A. Asthma / / Postgrad. Med. J.- 1996.- Vol.72,- P.12-18.
21. Carruthers N.I., Kaminski J.J. Recent developments with investigational drugs potentially useful in the treatm ent of allergic and inflammatory disorders / / Exp. Opin. Invest. Drugs.- 1995.- Vol.4.- P.1021 - 1025.
22. Carter G.W., Voung P.R., Albert D.R. et al. 5-Lipoxygenase inhibitory activity of Zeleuton / / J. Pharmacol. Exp. Ther.- * 1991.- Vol.256.- P.929-937.
23. Chanarin N., Johnston S.L. Leukotrienes as a target in asthma therapy / / Drugs.- 1994.- Vol.47.- P.12-24.
24. Christie P.E., Tagari P., Ford-Hutchinson A.W. et al. Urinary leukotriene E4 concentracions increase after aspirin challenge in aspirin-sensitive asthm atic subjects / / Am. Rev. Respir. Dis.- 1991.- Vol.143.- P.1025-1029.
25. Chung K.F. Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy / / Eur. Respir. J.- 1995,- Vol.8.- P.1203-1213.
26. Dahlen B. Leukotrienes as mediators of asthma induced by aspirin and allergen 1993, 1-68 / / ISBN: 91-628-0961-X.
27. Dahlen B., Dahlen S.E. Leukotrienes as mediators of airway obstruction and inflammation in asthma / / Clin. Exp. Allergy.- 1995.- Vol.25, Suppl. 2.- P.50-54.
28. Dahlen B., Zetterstrom O., Bjorck T. et al. The leukoctriene antagonist ICI-204219 inhibits the aerly airway reaction to cum ulative bronchial challenge with allergen in atopic asthm atics / / Eur. Respir. J.- 1994.- Vol.7.- P.324-331.
29. Dahlen S.E., Bjork J., Hedqvist P. et al. Leukotrienes promotes plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response / / Proc. Natl. Acad. Sci. USA.- 1981.- Vol.78.- P.3887-3891.
30. Dahlen S.E., Dahlen B., Kumlin M., Bjoerck T., Ihre E. Clinical and experimental studies of leukotrienes as mediators of airway obstruction in humans / / Adv. Prostagland. Thrombox. Leukotr. Res.- 1994.- Vol.22.- P.155-166.
31. Dahlen S.E., Hedqvist P., Hammarstrom S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi / / Nature.- 1980.- Vol.288.- P.484-486.
32. Daines R.A., Chambers P.A., Pendrak I. et al. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships / / J. Med. Chem.- 1993.- Vol.36.- P.3321-3332.
33. Dixon R.A.F., Diehl R.E., Opas E. et al. Requirement of a 5-lipoxygenase protein for leukotriene synthesis / / Nature.- 1990.- Vol.343.- P.282-284.
34. Drazen J. The role of leukotrienes in asthm a. M ediating the inflammation in asthma / / European Academy of Allergology and Clinical Immunology. Satellite Symposium.- Rotterdam, 1993.- P.4.
35. Drazen J.M., Austen K.F. Leukotrienes and airway responses / / Am. Rev. Respir. Dis.- 1987.- Vol.136.- P.985-988.
36. Drazen J.M., Lilly C.M., Sperling R., Rubin P., Israel E. Role of cysteinil leucotrienes in spontaneus asthmatic responses / / Adv. Prostagland. Thrombox. Leukotr. Res.- 1994.- Vol.22.- P.251-262.
37. Evans T.W., Rogers D.F., Aursudkij B. et al. Regional and time-dependent effects of inflammatory on airway microvascular permeability in the guinea-pig / / Clin. Sci.- 1989.- Vol.76.- P.479-485.
38. Findlay S.R., Barden J.M., Easley C.B. et al. Effect of the oral leukotriene antagonist JCJ 204. 219 on antigen-induced bronchoconstriction in subjects with asthma / / J. Allergy Clin. Immunol.- 1992.- Vol.89.- P. 1040- 1045.
39. Floreani A., Robbins R., Melson J., Rennard S. Inhibitory effect of LTD4 receptor antagonist ‘Accolate on agonistinduced bronchoconstriction in asthmatic subjects / / Ann. Allergy. Asthma Immunol.- 1996.- Vol.76.- P.98.
40. Ford-Hutchinson A.W., Bray M.A., Doig M.E. et al. Leukotriene B: a potent chemokinetic and aggregating sustance released from polymorphonuclear leukocytes / / Nature.- 1980.- Vol.286.- P.264.
41. Foster A., Chan C.C. Peptide leukotriene involment in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig / / Arch. Allergy Appl. Immunol.- 1991.- Vol.96.- P.279-284.
42. Friedman B.S., Bel E.H., Buntinx A. et al. Oral leukotriene inhibitor (MK-886) blocks allergen- induced airway responses / / Am. Rev. Respir. Dis.- 1993.- Vol.147.- P.839-844.
43. Fujimura M., Sakamoto S., Kamio Y. et al. Effect of a leukotriene antagonist ONO-1078 on bronchial hyperresponsiveness in patients with asthma / / Respir. Med.- 1993.- Vol.87.- P. 133- 138.
44. Fuller R.W., Black P.N., Dolley C.T. Effect of the oral leukotriene D4 antagonist LY 171883 on inhaled and inradermal challenge with antigen and leukotriene D4 in atopic subjects / / J. Allergy Clin. Immunol.- 1989.- Vol.83.- P.939- 944.
45. Gaddy J.N., Buch R.K., Margoleskee D. et al. The effects of leukotriene D4 antagonist (MK 571) in mild to moderate asthma / / J. Allergy Clin. Immunol.- 1990.- Vol.85.- P .195.
46. Gaddy J.N., Margoleskee D.J., Buch R.K. et al. The effects of a potent and selective leucotriene D4 antagonist (MK 571) in moderate asthm a / / Am. Rev. Respir. Dis.- 1992.- Vol. 146.- P.358-363.
47. Gillard J., Ford-Hutchinson A.W., Chan C. et al. MK-886, njvel orally active leukotriene biosynthesis inhibitor / / Can. J. Physiol. Pharm acol.- 1989.- Vol.67.- P.456-464.
48. Glass M. Initial results with oral administration of ICI 204219 / / Ann. N. Y. Acad. Sei.- 1991.- Vol.629.- P.143-147.
49. Haahtela T. The importance of inflammation in early asthma / / Respir. M ed.- 1995.- Vol.89, № 7.- P.461-462.
50. Harris R.R., Carter G.W., Bell R. et al. Clinical activity of leukotriene inhibitors / / Int. J. Immunopharmacol.- 1995.- Vol.17,- P.147-156.
51. Hay D.W.P., Muccietelli R.M., Tucker S.S. et al. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways / / J. Pharmacol. Exp. Ther.- 1987.- Vol.243.- P.474-481.
52. Hay D.W.P., Torphy T.J., Undem B.J. Cysteinyl leukotrienes in asthm a: old mediators up to new tricks / / Trends Pharmacol. Sei.- 1995.- Vol. 16.- P.304-309.
53. Hoover R.L., Karnovsky M.J., Austen K.F. et al. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion / / Proc. Natl. Acad. Sei. USA.- 1984.- Vol.81.- P.2191- 2193.
54. Hui K.P., Barnes N.C. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist / / Lancet.- 1991.- Vol.337.- P. 1062.
55. Hui K.P., Taylor J.K., Taylor G.W. et al. Effect of 5-Lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthm atic patients / / Thorax.- 1991.- Vol.46.- P.184- 189.
56. Hutchinson J.H., Reindeau D., Brideau C. et al. Thiopyrano [ 2, 3, 4 - cd] indoles as 5-Lipoxygenase inhibitors: synthesis, biological profile / / J. Med. Chem.- 1994.- Vol.37.- P.l153-1164.
57. Ishichara Y., Uchida Y., Kitamura S. Measurement of leukotrienes in peripheral venous blood from patients with bronchial asthm a / / Clin. Res.- 1985.- Vol.33.- P.466A.
58. Israel E., Dermarkarian R., Rosenberg M. et al. The effects of 5-lipoxygenase inhibitor on asthm a induced by cold dry air / / N. Engl. J. M ed.- 1990.- Vol.323.- P.1740-1744.
59. Israel E., Drazen J., Cohn J., Rubin P. A double blind m ulticenter study of Zileuton, a potent 5-Lipoxygenase inhibitor versus placebo in the treatm ent of spontaneous asthm a in adults / / J. Allergy Clin. Immunol.- 1992.- Vol.89.- P.236-238.
60. Israel E., Rubin P., Kemo I.P. et al. The effect of inhibition of 5-lipoxigenase by zileuton in mild-to-moderate asthm a / / Ann. Intern. M ed.- 1993.- Vol.119.- P.1059-1066.
61. Jacobs R.T., Veale C.A., Wolanin D.J. Pulmonary and antiallergy agents / / Annu. Rep. Med. Chem.- 1992.- Vol.27.- P. 109-118.
62. Jones T.R., Zamboni R., Belley M. et al. Pharmacology of L-660711 (MK 571): a novel potent and selective leukotriene D4 receptor antagonist / / Can. J. Physiol. Pharmacol.- 1989.- Vol.67.- P. 17-28.
63. Joris J., Majno G., Corey E.J., Lewis R.A. The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction / / Am. J. Pathol.- 1987.- Vol. 126.- P. 19-24.
64. Kaliner M.A. Allergic inflammation and asthm a / / Prog. Allergy Clin. Immunol.- 1994.- Vol.3.- P.301-304.
65. Kikawa V., Hosoi S., Inoue V. et al. Exercise-induced urinary excretion of leukotriene E4 in children with atopic asthma / / Pediatr. Res.- 1991.- Vol.29.- P.455.
66. Knapp H.R. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor / / N. Engl. J. M ed.- 1990.- Vol.323.- P. 1745-1748.
67. König W., Schonjeld W., Raaulf M. et al. The neutrophil and leukotrienes - basic in health and disease / / Eucosanoids.- 1990.- Vol.3.- P .l- 22.
68. Krell R.D., Aharony D., Bucker C.K. et al. The preclinical of ICI 204219, a peptide leukotriene antagonist / / Am. Rev. Respir. Dis.- 1990,- V ol.141.- P.978-987.
69. Kumlin M., Dahlen B., Bjouck T. et al. Urinary exretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4 and histamine in asthm atics / / Am. Rev. Respir. Dis.- 1992.- Vol.146.- P.96-103.
70. Labat C., Ortiz J.L., Norel X. et al. A second cysteinyl leukotriene receptor in human lung / / J. Pharmacol. Exp. Ther.- 1992.- Vol.63.- P.800-805.
71. Laitinen L.A., Laitinen A., Haahtela T. et al. Leukotriene E4 and granulocytic infiltration into asthm atic airways / / Lancet.- 1993.- Vol.341.- P.989-990.
72. Lam S., Chan H., LeRiche J.C. et al. Realese of leukotrienes in patients with bronchial asthm a / / J. Allergy Clin. Immunol.- 1988,- Vol.81.- P.1711 - 1717.
73. Lammers J.W., Cheng J.B. Early efficacy data with a newer generation of LTD4 antagonists in anti-asthma trials / / Pulmon. Pharmacol.- 1992.- Vol.5.- P.121 - 125.
74. Lay S.R., Barden J.M ., Easley C.B. et al. Effect of the oral leukotriene antagonist JC J 204219 on antigen-induced bronchoconstriction in subjects with asthm a / / J. Allergy Clin. Im munol.- 1992.- Vol.89.- P.1040- 1045.
75. Larsen J.S. Leukotriene - receptor antagonists and 5 - lipoxygenase inhibitors in asthm a / / Ann. Pharm acother.- 1993.- Vol.27.- P.898-903.
76. Lazarus S.T., Lavins B.J., Wong H., Watts M.J., Minkwitz M.C. Effect of oral ‘Accolate’ on sulfur dioxide (S02) - induced bronchoconstriction in patients with asthm a / / Am. J. Respir. Crit. Care M ed.- 1995.- V ol.151, Pt 2.- P.A41.
77. Maclouf J., Fitzpatrick F.A., Murphy R.C. Transcellular biosynthesis of eicosanoids / / Pharmacol. Res.- 1989.- Vol.21.- P .l-7.
78. Makker H.K., Lau L.C., Thomson H.W. et al. The protective effect of inhaled leucotriene D4 receptor antagonist ICI 204219 against exercise - induced asthm a / / Am. Rev. Respir. Dis.- 1993.- V ol.147, Pt 1.- P.1413-1418.
79. Manning P.J., Rokach J., Malo J.-L. et al. Urinary leukotriene E4 levels during early and late asthm atic responses / / J. Allergy Clin. Immunol.- 1990.- Vol.86.- P .211-220.
80. Manning P.J., Watson R.M., Morgolskee D.J. et al. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4 receptor antagonist / / N. Engl. J. M ed.- 1990.- Vol.323.- P. 1736-1739.
81. Margolskee D., Bodtnan S., Dockhorn R. et al. The therapeutic effects of MK-571, a potent and selective leukotriene D4, receptor antagonist in patients with chronic asthm a / / J. Allergy Clin. Immunol.- 1991.- Vol.87.- P.309.
82. Marom Z.V.L., Shelhamer J.H., Bach M.K. et al. Slow-reacting substance, leukotrienes C4 and D4, icrease the realease of mucus from human airways in vitro / / Am. Rev. Respir. Dis.- 1982.- Vol.126.- P.449-451.
83. Miller D.K., Gillard J.W., Vickers P.J. et al. Indentification and isolation of a membrane protein necessary for leukotriene production / / N ature.- 1990.- Vol.343.- P.278-281.
84. Morris H.R., Taylor G.W., Piper P.J., Tippins J.R. Structure of slow reacting substance of anaphylaxis from guinea-pig lung / / Ibid.- 1980.- Vol.285.- P.104-106.
85. Murphy R.C., Hammarstrom S., Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells / / Proc. Natl. Acad. Sei. USA.- 1979.- Vol.76.- P.4275-4279.
86. Nakai H., Konno M., Kosuge S. et al. New potent antagonist of leukotrienes C4 and D4 1. Synthesis and structure-activity relationships / / J. Med. Chem.- 1988.- Vol.34.- P.84.
87. Nakagawa N., Obata T. Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthm a / / Eur. J. Pharmacol.- 1993.- Vol.235.- P .211-219.
88. Obata T., Okada Y., Motoishi M. et al. In vitro antagonism ONO-1078, a newly developed antiasthm a agent, against peptide leukotrienes in isolated guinea pig tissues / / Jap. J. Pharm acol.- 1992.- Vol.60.- P.227-230.
89. O’Hickey S.P., Hawksworth J., Fong C.V. et al. Leukotrienes C4D4-E4 enhance histamine responsiveness in asthm atic airways / / Am. Rev. Respir. Dis.- 1991.- V ol.144.- P .1053-1057.
90. Ohmi Naoko, Tani C., Yamada K., Fukui M. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178 / / Iflammation.- 1994.- V ol.18.- P.129-140.
91. Picado C., Ramis I., Rosello J. et al. Release of peptide leukotriene in to nasal secretions after local instillation of aspirin in aspirin sensitive asthm atic patients / / Am. Rev. Respir. Dis.- 1991.- Vol.145.- P.65-69.
92. Piper P.J. Formation and actions of leukotrienes / / Pharmacol. Rev.- 1984.- Vol.64.- P.744-761.
93. Piper P.J. Leukotriene in airways and blood vessels / / Arzneim.- Forsch.- 1989.- Bd 39.- S. 1005-1009.
94. Piper P.J. Leukotrienes: potent mediators of airway constriction / / Int. Arch. Allergy Appl. Immunol.- 1985.- Vol.76, Suppl. 1.- P.43-48.
95. Rasmussen J.B., Morgolskee D.J., Eriksson L.O. et al. Leukotriene (LT) D4 is involved in antigen- induced asthma: a study with the LTD4 receptor antagonist MR- 571 / / Ann. N. Y. Acad. Sei.- 1991.- Vol.629.- P.436.
96. Roquet A., Dahlen B., Ihre E. et al. Cysteinyl-leukotriens and histamine account for predominant components of early and late phase airway obstruction evoked by allergene-challenge of asthmatics / / Am. J. Respir. Crit. Care Med.- 1996.- Vol. 154, № 4.- Pt 2.- P.A214.
97. Rouzer C.A., Ford-IJutchinson A.W., Morten H.E. MK-886, a potent and specific leukotriene biosynthesis inhibitor, blocks and reverses the membrane association of 5-lipoxygenase in ionophore challenged leukocytes / / J. Biol. Chem.- 1990.- Vol.265.- P.1436-1442.
98. Rouzer C.A., Kargman S. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187 / / Ibid.- 1988.- Vol.263.- P.10980-10988.
99. Sakakibara H., Hirose K., Okawara S. Peptidoleukotriene receptor antagonists / / Nippon Rinsho.- 1996.- Vol.54.- P.3049-3055.
100. Salari H., Borgeat P., Fournier M. et al. Studies of the release of leukotrienes and histamine by human lung parenchymal and bronchial frafments upon immunologic and nonimmunologic stim ulation / / J. Exp. M ed.- 1985.- Vol.162.- P.1904-1915.
101. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reaction and inflammation / / Science.- 1983.- Vol.220.- P.568.
102. Satoh Y., Stanton J.L., Hutchinson A.J. et al. Substituted Chromenes as potent, orally active 5-lipoxigenase inhibitors / / J. Med. Chem.- 1993.- Vol.36.- P.3580-3594.
103. Schroer K. Pharmacology of allergic inflammation: new approaches to drug treatm ent by selective modulation of the formation and action of aicosanoids / / Allergologie.- 1992.- Vol. 15.- P.330-335.
104. Shaw A., Krell R.D. Peptide leukotriens: current status of research / / J. Med. Chem.- 1991.- Vol.34, № 4.- P.1235-1242.
105. Smith M.J.H., Ford-Hutchinson A.W., Bray M.A. Leukotriene B: a potencial mediator of inflammation / / J. Pharm. Pharmacol.- 1980.- Vol.32.- P.517-518.
106. Smith L.J., Geller S., Edright L. et al. Inhibition of leukotriene (LT) D4-induced bronchoconstriction in asthm atic subjects by the oral LTD4 receptor antagonist ICI 204219 / / Am. Rev. Respir. Dis.- 1990.- Vol.141.- P.A33.
107. Tagari P., Becker A.B., Brideau C. et al. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591 / / J. Pharmacol. Exp. Their.- 1993.- Vol.265.- P.416-425.
108. Tagari P., Rasmussen J.B., Delore D. et al. Comparison of urinary leukotriene E4 and 16-carboxytetranordihydroleukotriene E4 excretion in allergic asthm atics after inhaled antigen / / Eicosanoids.- 1990.- Vol.3.- P.75-80.
109. Taniguchi Y., Tamura G., Honma M. et al. The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthm atic subjects / / J. Allergy Clin. Immunol.- 1993.- Vol.92.- P.507-512.
110. Taylor I.K. Cysteinyl leukotriene in asthma: current state of therapeutic evalution / / Thorax.- 1995.- Vol.50.- P. 1005-1010.
111. Taylor G.W., Black P., Turner N. et al. Urinary leukotriene E4 after antigen challenge in acute asthma and allergic rhinitis / / Lancet.- 1989.- V ol.l.- P.584-588.
112. Taylor I.K., O’Shaughnessy K.M., Choudry N.B. et al. A comparative stady in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity and increase in urinary leukotriene E4 excretion / / J. Allergy Clin. Immunol.- 1992.- Vol.89.- P.575-583.
113. Taylor W.A. Eicosanoids in asthma: the therapeutic options / / Perspectives in Medicinal Chemistry / Ed. B. Testa, E. Kuburz et al.- Weinheim, 1993.- P.445-458.
114. Virchow J.C., Kroegel C., Luttman W. et al. Leukotriene-receptor-antagonists, 5-lipoxygenase-activating-protein inhibitors - a new form of therapy in bronchial asthma / / Allergologie.- 1996.- Vol.19, № 1.- P.3-14.
115. Wardlaw A.J., Hay H., Cromwell O. et al. Leukotrienes, LTC4 and LTD4 in bronchoalveolar lavage in bronchial asthma and respiratory diseases / / J. Allergy Clin. Immunol.- 1989.- Vol.84.- P. 19-26.
116. WEI Er-Qing, XIN Xiao-Hua et al. Effects of ONO-1078, a lekotriene antagonist, on cardiovascular responses induced by vagal stimulation, capsaicin, and substance P in guinea pigs / / Acta Pharmacol. Sin.- 1995.- Vol.16.- P.485-488.
117. Weiss J.W., Drazen J.M., Coles H. Bronchoconstrictor effects of leukotriene C in humans / / Science.- 1982.- Vol.216.- P.196-198.
118. Whealan C.J. Prospects for the development of new drags for the therapy of respiratory diseases / / Drugs Today.- 1996.- Vol.32.- P.295-311.
119. Woodward D.F., Weichman B.M., Gill C.A., Wasserman M.A. The effect of synthetic leukotrienes on tracheal microvascular permeability / / Prostaglandins.- 1983.- Vol.25.- P.131-142.
120. Zakrzewski J.T., Barnes H.C., Piper P.J. Quantitation of leukotrienes in asthmatic sputum / / Br. J. Pharmacol.- 1985.- Vol.19.- P.574.
Рецензия
Для цитирования:
Ковалева В.Л., Чучалин А.Г., Колганова Н.А. Антагонисты и ингибиторы лейкотриенов в терапии бронхиальной астмы. Пульмонология. 1998;(1):79-87.
For citation:
Kovaleva V.L., Chuchalin A.G., Kolganova N.A. Leucotriene antagonists and inhibitors in bronchial asthma treatment. PULMONOLOGIYA. 1998;(1):79-87. (In Russ.)
Просмотров:
310
ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)
ISSN 2541-9617 (Online)
Послать статью по эл. почте 